Effect of Unani formulation in Acne Vulgaris
Phase 2
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2022/08/044595
- Lead Sponsor
- Government Unani Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of age group 15 to 35years
Both the genders
Clinically diagnosed patients of Acne vulgaris
Patients with a score of 1 to 30 that is mild to moderate according to GAGS
Patients or Guardians who agree to sign the informed consent form and follow the protocol
Exclusion Criteria
Age less than 15 and more than 35 years
Patients having local wound and infection on face
Pregnant and lactating women
Mentally retarded
Patients with systemic diseases like Tuberculosis Bronchial Asthma DM HTN and CKD
Patients on corticosteroid therapy anticonvulsant therapy using retinoid or taking OCP
Patients who do not cooperate and fail follow up
Patients whose GAGS was assessed to be severe and very severe a score which is more than or equal to 31
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of acne in photographs <br/ ><br>Improvement in GAG score <br/ ><br>Improvement in Cardiff acne disability index <br/ ><br>Timepoint: 0th,7th,14th 21st day
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil